UPB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Upstream Bio Inc (UPB) is not a strong buy at this time for a beginner investor with a long-term strategy. While the RSI indicates the stock is oversold, the overall technical indicators are bearish, and there are no significant positive catalysts or trading signals to suggest immediate upside potential. The financial performance shows improvement in losses but remains negative overall, and there is no recent news or analyst sentiment to support a buy decision.
The technical indicators for UPB are bearish. The MACD histogram is negative and contracting, the RSI indicates an oversold condition at 12.678, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 7.664), but the pivot point is significantly higher at 10.399, indicating limited upward momentum in the short term.
The RSI indicates the stock is oversold, which could attract buyers. The company's financials show YoY improvement in revenue, net income, and EPS, suggesting progress.
The overall technical trend is bearish, with negative MACD and bearish moving averages. There is no recent news or significant hedge fund or insider activity to support a positive sentiment. The stock's historical volatility is high (218.79), which may deter long-term investors.
In Q3 2025, revenue increased by 12.52% YoY to $683,000. Net income improved by 60.45% YoY but remains negative at -$33.75M. EPS improved by 53.66% YoY to -0.63. Gross margin remains at 100%. While there is improvement, the company is still unprofitable.
No recent analyst ratings or price target changes are available for UPB.
